New treatment shows promise for Tough-to-Treat adult leukemia
NCT ID NCT03751072
Summary
This study looked at how well a drug called blinatumomab worked for 92 adults in France with a type of blood cancer called B-cell acute lymphoblastic leukemia (ALL). The patients had cancer that had come back, didn't respond to other treatments, or had small amounts of cancer cells left after initial therapy. Researchers tracked how long patients lived, whether the cancer responded to the drug, and what side effects occurred.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA, IN RELAPSE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CABANNES-HAMY Aurélie
Paris, 75010, France
Conditions
Explore the condition pages connected to this study.